MyFinsight
Home
Blog
About
Contact
Download
Download image
Common stock issuance
(net of fees)
$7,858,140
Sale of preferred
stock
$1,053,000
Prepaid warrants (net of
fees)
$530,162
Net cash provided by
financing activities
$9,441,302
Net change in cash
-$5,263,697
Canceled cashflow
$9,441,302
Accounts payable
$8,274,316
Stock-based compensation
$4,265,957
Amortization of non-cash
prepaids
-$1,037,631
Accrued expenses
$893,992
Common shares issuance
for services
$595,841
Commitment shares issued
for equity line of...
$568,235
Depreciation and
amortization expense
$363,085
Net cash used in
operating activities
-$14,238,576
Canceled cashflow
$15,999,057
Net cash used in
investing activities
-$466,423
Net loss
-$28,753,844
Change in value of
warrant liabilities
-$1,424,603
Accrued payroll and
payroll taxes
-$59,186
Patent license
acquisition
$466,423
Back
Back
Cash Flow
source: myfinsight.com
OS Therapies Inc (OSTX)
OS Therapies Inc (OSTX)